| Atopic dermatitis |
No increased risk of allergic reactions to COVID-19 vaccination. Vaccination possible at any time. Short-term eczema aggravation possible due to vaccination. |
Vaccination can be applied at any time under dupilumab. Vaccination is recommended between two dupilumab injections with 1 week interval between vaccination and this biological treatment. |
| Chronic spontaneous urticaria |
No increased risk of allergic reactions to COVID-19 vaccination. Vaccination possible at any time. Short-term eczema aggravation possible due to vaccination. |
Vaccination can be applied at any time under omalizumab. Intervals between vaccinations and biological therapies as outlined above should be followed. |
| Bronchial asthma |
No increased risk of allergic reactions to COVID-19 vaccination. Vaccination possible at any time. |
Vaccination is recommended in patients with severe asthma and concurrent biological treatment. Intervals between vaccinations and biological therapies as outlined above should be followed. |
| Chronic rhinosinusitis with polyps (CRSwNP) |
No increased risk of allergic reactions to COVID-19 vaccination. Vaccination possible at any time. |
Continuation or initiation of biological therapy in CRSwNP is recommended (if indicated) with concurrent vaccination. Intervals between vaccinations and biological therapies as outlined above should be followed. |
